[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Maroni et al., 1997 - Google Patents

Role of nutrition in prevention of the progression of renal disease

Maroni et al., 1997

Document ID
3512341575068263378
Author
Maroni B
Mitch W
Publication year
Publication venue
Annual review of nutrition

External Links

Snippet

▪ Abstract In rats with renal disease, low-protein diets slow the decline in renal function, histologic damage, and mortality. Low-protein (and phosphorus) diets can also ameliorate uremic symptoms, secondary hyperparathyroidism, and metabolic acidosis in patients with …
Continue reading at www.annualreviews.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Maroni et al. Role of nutrition in prevention of the progression of renal disease
Bernhard et al. Adaptive response to a low-protein diet in predialysis chronic renal failure patients
Balaji et al. Complications of diabetes mellitus: A review.
Schnorf et al. Ciguatera fish poisoning: a double-blind randomized trial of mannitol therapy
Ney et al. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial
Moore et al. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes
Daniel et al. Isopropyl alcohol metabolism after acute intoxication in humans
Møller et al. Plasma amino acids as an index for subgroups in manic depressive psychosis: correlation to effect of tryptophan
Zaman et al. Isopropyl alcohol intoxication: a diagnostic challenge
Blicklé et al. Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7–8% A1c levels. The TULIP study
Rasmussen et al. Determination of the safety of leucine supplementation in healthy elderly men
Fouque et al. Low-protein diets in chronic kidney disease: are we finally reaching a consensus?
AbdulRasoul et al. A comparison of continuous subcutaneous insulin infusion vs. multiple daily insulin injection in children with type I diabetes in Kuwait: glycemic control, insulin requirement, and BMI
Ludvigsson et al. Treatment with antioxidants at onset of type 1 diabetes in children: a randomized, double‐blind placebo‐controlled study
Zarazaga et al. Nutritional support in chronic renal failure: systematic review
Larivière et al. Effects of dietary protein restriction on glucose and insulin metabolism in normal and diabetic humans
Chiu et al. Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies
Young et al. A longitudinal study of the effects of amino acid-based CAPD fluid on amino acid retention and protein losses
Forst et al. Role of C-Peptide in the regulation of microvascular blood flow
Bushinsky, MD Bone disease in moderate renal failure: Cause, nature, and prevention
Davidson et al. Lack of dialyzable insulin antagonist in uremia
Aquilani et al. Normalization of zinc intake enhances neurological retrieval of patients suffering from ischemic strokes
Makhzoumi et al. Diabetic ketoacidosis associated with aripiprazole
Lin et al. Toxicity, bioavailability and pharmacokinetics of a newly formulated colistin sulfate solution
Malik Rhabdomyolysis and myoglobin-induced acute renal failure